TOKYO -- Drugmakers in Japan, U.S. and Europe are teaming up to discover new drugs based on human genetic data. Led by the National Cancer Center of Japan, the joint research by private companies and academic institutions will collect genetic information from cancer patients to build a database for clinical trials.
Takeda Pharmaceutical is participating in a joint project in Japan to develop new genomic cancer treatments. The genomic screening project, called Scrum-Japan, involves 13 drugmakers including Takeda Pharmaceutical and Astellas Pharma from Japan and U.S. drug company Pfizer.
